A report of the first clinical tests using the Rauwolfia alkaloid, ajmaline, as sysnptomatic therapeutic substance in disturbances of heart rhythm. In contrast to quinidine and procainamide, this substance can be used without danger of collapse. After administration of 50 mg ajmaline there is nearly always an interruption of the extrasystolic rhythm. The effect is, however, of relatively short duration as is also the case after intramuscular application. With oral administration also extrasystoles of various origins can be eliminated in more than half the cases. The use of ajmaline in other rhythmic disturbances is partly described and partly discussed. /Originally published in German in Med. Klin (Munich). 1959. 54: 409-416;translated by PANSDOC/.